ABSTRACT NUMBER: ESOC2026A2346 TEMPORAL MUSCLE THICKNESS TO SUPPORT REVASCULARIZATION DECISIONS IN ACUTE ISCHAEMIC STROKE

Abstract Background and aims Temporal muscle thickness (TMT), measured on routine non-contrast computed tomography (NCCT), is increasingly used as a reliable surrogate marker of global sarcopenia. When evaluating eligibility for reperfusion therapies in acute ischemic stroke (AIS), objective assessment of pre-stroke functional status may be challenging. TMT may provide an imaging-based biomarker to support estimation of pre-stroke disability, assessed using the modified Rankin Scale (mRS). This study aimed to evaluate the association between TMT and pre-stroke functional status in patients with AIS. Methods We included all adult consecutive patients treated for AIS at a tertiary centre during a period of 6 months. TMT was measured on admission NCCT by neuroradiologist blinded to clinical variables, according to a standardized protocol. Results A total of 404 patients were analysed (mean age 76.6 years). Patients with pre-stroke mRS 0–1 (group 1) and pre-stroke mRS 2 (group 2) demonstrated the highest mean TMT (6.6 [1.9] mm and 6.6 [2.1] mm, respectively). Mean TMT was lower in patients with pre-stroke mRS 3 (group 3; 5.5 [1.6] mm) and lowest in those with pre-stroke mRS 4–5 (group 4; 4.5 [1.4] mm). Overall, a significant difference in mean TMT was observed across pre-stroke mRS groups (one-way ANOVA, F = 13.62; df = 3,387; p < 0.001). Conclusions TMT is an easily obtainable value measured on NCCT. It may aid objective assessment of pre-stroke functional status helping guide revascularization therapy decision-making. Acknowledgements Horizon Europe project CHAngeing – Connected Hubs in Ageing: Healthy Living to Protect Cerebrovascular Function (Grant Agreement No. 101087071). Conflict of interest Katarina Rados: nothing to disclose, Andre Alves: nothing to disclose, Marcelo Queiroz: nothing to disclose, Joao Andre Sousa: nothing to disclose, Henrique Queirós: nothing to disclose, Fernando Silva: nothing to disclose, Gustavo Santo: nothing to disclose, Emanuel Martins: nothing to disclose, Branko Malojcic: nothing to disclose, Joao Sargento-Freitas: nothing to disclose Figure 1 - belongs to Results

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1081
Primary Topic
Nutrition and Health in Aging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A2346 TEMPORAL MUSCLE THICKNESS TO SUPPORT REVASCULARIZATION DECISIONS IN ACUTE ISCHAEMIC STROKE

Katarina Radoš, F. Silva, Gustavo António Pereira R Cordeiro Santo, João André Sousa et al.
European Stroke Journal
Nutrition and Health in Aging
article

ABSTRACT NUMBER: ESOC2026A2346 TEMPORAL MUSCLE THICKNESS TO SUPPORT REVASCULARIZATION DECISIONS IN ACUTE ISCHAEMIC STROKE

Katarina Radoš, F. Silva, Gustavo António Pereira R Cordeiro Santo, João André Sousa, Emanuel Martins, Branko Malojcic, Marcelo Queiroz, Henrique Queirós, João Sargento Freitas, Andre Alves
article en

Abstract

Abstract Background and aims Temporal muscle thickness (TMT), measured on routine non-contrast computed tomography (NCCT), is increasingly used as a reliable surrogate marker of global sarcopenia. When evaluating eligibility for reperfusion therapies in acute ischemic stroke (AIS), objective assessment of pre-stroke functional status may be challenging. TMT may provide an imaging-based biomarker to support estimation of pre-stroke disability, assessed using the modified Rankin Scale (mRS). This study aimed to evaluate the association between TMT and pre-stroke functional status in patients with AIS. Methods We included all adult consecutive patients treated for AIS at a tertiary centre during a period of 6 months. TMT was measured on admission NCCT by neuroradiologist blinded to clinical variables, according to a standardized protocol. Results A total of 404 patients were analysed (mean age 76.6 years). Patients with pre-stroke mRS 0–1 (group 1) and pre-stroke mRS 2 (group 2) demonstrated the highest mean TMT (6.6 [1.9] mm and 6.6 [2.1] mm, respectively). Mean TMT was lower in patients with pre-stroke mRS 3 (group 3; 5.5 [1.6] mm) and lowest in those with pre-stroke mRS 4–5 (group 4; 4.5 [1.4] mm). Overall, a significant difference in mean TMT was observed across pre-stroke mRS groups (one-way ANOVA, F = 13.62; df = 3,387; p < 0.001). Conclusions TMT is an easily obtainable value measured on NCCT. It may aid objective assessment of pre-stroke functional status helping guide revascularization therapy decision-making. Acknowledgements Horizon Europe project CHAngeing – Connected Hubs in Ageing: Healthy Living to Protect Cerebrovascular Function (Grant Agreement No. 101087071). Conflict of interest Katarina Rados: nothing to disclose, Andre Alves: nothing to disclose, Marcelo Queiroz: nothing to disclose, Joao Andre Sousa: nothing to disclose, Henrique Queirós: nothing to disclose, Fernando Silva: nothing to disclose, Gustavo Santo: nothing to disclose, Emanuel Martins: nothing to disclose, Branko Malojcic: nothing to disclose, Joao Sargento-Freitas: nothing to disclose Figure 1 - belongs to Results

European Stroke JournalVol. 11(Supplement_1)
University Hospital Centre Zagreb (HR), Polytechnic Institute of Coimbra (PT)
Openalex Percentile: Top 10%
Nutrition and Health in Aging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.